Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.

Infect Dis Ther · 2016 · PMC5019977 · PMID 27432414

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, patients with polymicrobial pneumonia had a better cure rate when they were treated with vancomycin (79.4%) compared to telavancin (66.2%), even though the difference did not reach statistical significance [ 4 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.